S. Talaneh, A. Hosein zadeh, and B. Jafari, “Treatment of advanced medullary thyroid cancer with an alternating 5 FU-dacarbazine”, Int Pharm Acta, vol. 1, no. 1, pp. 157–158, Mar. 2018.